Clinical Trial Update: Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous immunoglobulin for donors to reduce donor-derived infections, with conditions including viremia, bacteremia, and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Rejection of Renal Transplant
• Viremia

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Viremia, Bacteremia | Phase 4 | Status: UNKNOWN